Pear Therapeutics, Inc.
PEARDelisted- Industry
- Services-Health Services
- SEC CIK
- 0001835567
Pear Therapeutics, Inc. was delisted in 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.8M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pear Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pear Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rocklage Scott M | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| Diekman John D | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| 5AM Partners IV, LLC | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| 5AM Ventures IV, L.P. | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| 5AM Co-Investors IV, L.P. | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| Schwab Andrew J. | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| 5AM Opportunities I, L.P. | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 200,000Indirect | Apr 12, 2023 | 0 |
| Guiffre Christopherd T | CFO, COO, Treas., & Asst. Sec. | 29,960 | Feb 17, 2023 | 0 |
| Wicks Timothy A | Director | 52,380 | Feb 17, 2023 | 0 |
| Schlichting Nancy M | Director | 66,666 | Feb 17, 2023 | 0 |
| Bauerlein Alison | Director | 71,428 | Feb 17, 2023 | 0 |
| Snow Ellen | VP, Chief Accounting Officer | 23,318 | Feb 17, 2023 | 0 |
| Rajaraman Shivakumar | Director | 52,380 | Feb 17, 2023 | 0 |
| Brenner Erin K. | Chief Product Dev. Officer | 43,310 | Feb 17, 2023 | 0 |
| Maricich Yuri | Chief Medical Officer | 94,333 | Feb 17, 2023 | 0 |
| McCann Corey | President and CEO | 8,210,834 | Feb 17, 2023 | 0 |
| O'Brien Ronan | CCO, GC, & Secretary | 18,638 | Feb 17, 2023 | 0 |
| Reddy Kirthiga | Director | 61,904 | Feb 17, 2023 | 0 |
| Strandberg Julia | Chief Commercial Officer | 28,612 | Feb 17, 2023 | 0 |
| Mango Paul | Director | 52,380 | Feb 17, 2023 | 0 |
| Jeffery Katherine | Chief People Officer | 8,304 | Jan 24, 2023 | 0 |
| LJ10 LLC | 10% Owner | 6,110,000 | Dec 13, 2022 | 0 |
| KLP Spac 1 LLC | 10% Owner | 6,110,000 | Dec 13, 2022 | 0 |
| Gomez Jorge M | Director | – | Dec 7, 2021 | 0 |
| Lynch Zack | Director | 9,681,673Indirect | Dec 7, 2021 | 0 |
| Christenson Michael J | Other: See Remarks | – | Dec 6, 2021 | 0 |
| Fitzgerald Meghan | Other: See Remarks | – | Dec 6, 2021 | 0 |
| Benson Steven J. | Other: See Remarks | – | Dec 6, 2021 | 0 |
| Miller Henry S | Other: See Remarks | – | Dec 6, 2021 | 0 |
| Boms Elon | Other: See Remarks | – | Dec 6, 2021 | 0 |
| Iannotta Joseph | Other: See Remarks | – | Dec 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 (view filing)4:51 PM ET | Apr 10 | 2 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −16.5M | $0.12 | −$1.99M | −98.8%200.0K after | 3 lots |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | O'Brien RonanGC, CCO & Secretary | SSaleClass A Common Stock | −12.2K | $1.13 | −$13.7K | −39.5%18.6K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Strandberg JuliaChief Commercial Officer | SSaleClass A Common Stock | −12.7K | $1.13 | −$14.3K | −30.7%28.6K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Brenner Erin K.Chief Product Dev. Officer | SSaleClass A Common Stock | −8.69K | $1.13 | −$9.82K | −16.7%43.3K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Snow EllenChief Accounting Officer | SSaleClass A Common Stock | −8.03K | $1.13 | −$9.07K | −25.6%23.3K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Guiffre Christopherd TCFO, COO, Treas., & Asst. Sec. | SSaleClass A Common Stock | −19.5K | $1.13 | −$22.1K | −39.5%30.0K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Maricich YuriChief Medical Officer | SSaleClass A Common Stock | −12.2K | $1.13 | −$13.7K | −11.4%94.3K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | McCann CoreyPresident and CEO | SSaleClass A Common Stock | −34.7K | $1.13 | −$39.2K | −0.4%8.21M after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Jeffery KatherineChief People Officer | SSaleClass A Common Stock | −7.10K | $1.13 | −$8.02K | −46.1%8.30K after | |
| Nov 15, 2022 (view filing)8:32 PM ET | Nov 11-15 | 4 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −105.3K | $2.74 | −$288.3K | −16.4%534.9K after | 6 lots |
| Nov 2, 2022 (view filing)7:49 PM ET | Oct 31-Nov 2 | 2 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −54.2K | $2.77 | −$150.1K | −9.1%539.1K after | 6 lots |
| Sep 16, 2022 (view filing)6:03 PM ET | Sep 14-16 | 2 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −558.2K | $1.88 | −$1.05M | −50.8%541.2K after | 6 lots |
| Sep 8, 2022 (view filing)8:01 PM ET | Sep 6-8 | 2 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −770.0K | $2.05 | −$1.58M | −57.7%563.6K after | 6 lots |
| Aug 18, 2022 (view filing)8:05 PM ET | Aug 16-18 | 2 days | Rocklage Scott M and 7 others10% Owner | SSaleClass A Common Stock | −400.0K | $1.65 | −$660.1K | −40.2%594.4K after | 6 lots |